Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Hydrogenolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106986846B details a safe formic acid method for methylfuran. Reduces costs and improves supply chain reliability for fine chemical intermediates.
Discover the advanced synthesis of Entecavir via Patent CN100379736C. A cost-effective, scalable route eliminating toxic reagents for high-purity antiviral API manufacturing.
Novel two-step synthesis of (5-fluoropyrimidin-4-yl) methanol via oxidation and dechlorination. Offers streamlined manufacturing and cost reduction for API intermediates.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Novel furfural-based route offers high selectivity and mild conditions for 5-AP production ensuring cost reduction in pharma intermediate manufacturing and supply stability.
Novel catalytic hydrogenolysis route improves yield and purity of 2-hydrazinopyridine derivatives, offering cost-effective supply chain solutions.
Advanced preparation of Silodosin intermediate via novel Friedel-Crafts route. Offers high optical purity, reduced toxicity, and scalable manufacturing for global supply chains.
Patent CN108358760A reveals a safer metal hydride palladium system for debenzylation. This breakthrough offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel patent CN109678855A offers high-yield Avibactam intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN111978320B reveals a high-yield two-step route for renin inhibitor intermediates, offering significant cost reduction in API manufacturing and scalable production.
Novel preparation method for Tezacaftor via reductive cyclization. High purity, low cost, scalable industrial process for API intermediates.
Patent CN112979498A reveals a high-yield synthesis route for 3-fluoro-4-trifluoromethyl benzonitrile, offering cost reduction in API manufacturing and improved supply chain reliability.
Novel patent CN115611860B details a safer high-yield nilaparib synthesis route eliminating sodium azide and chiral resolution for cost-effective manufacturing and supply chain stability.
Patent CN102093292A reveals a safe two-step route for DL-alpha-aminocaprolactam, eliminating toxic azides for reliable pharmaceutical intermediates manufacturing.
Patent CN115611860A discloses a safe, high-yield Niraparib synthesis avoiding sodium azide. Ideal for cost reduction in API manufacturing and supply chain stability.